• Achillion Pharmaceuticals, Inc. (ACHN)'s Hepatitis C Drug Gets FDA Fast Track More...

• Cubist Pharmaceuticals, Inc. (CBST) Announces First Scientific Presentations of Phase 2 Data for CB-5945 in the Treatment of Opioid-Induced Constipation More...

• Achaogen Announces All Objectives Met in Phase 2 Plazomicin Complicated Urinary Tract Infections Study and Start of First-in-Human Study with ACHN-975 More...

• Helix Biopharma (CC:HBP) Commences Polish Phase I/II Clinical Study of Its Lung Cancer Drug Candidate L-DOS47 More...

• Hospira, Inc. (HSP) Recalls Pain Drug Cartridges More...

• TG Therapeutics, Inc. Announces Investigational New Drug (IND) for TGTX-1101, Receives Clearance by the FDA to Commence Clinical Trials in the U.S. More...

• Touch Sensitivity is Genetically Linked to Hearing, Max Delbruck Center Study More...

• Brain Circuitry is Different for Women With Anorexia and Obesity, University of Colorado Study More...

• Playful Games Promote Reading Development, University of Gothenburg Study More...

• Pulmatrix Demonstrates iSPERSE Capabilities for Inhaled Dry Powder Delivery of Antibiotics and Antibodies More...

• Liquidia Technologies Inc. Studies Show PRINT® Engineered Particles Hold Promise in the Delivery of Respiratory Therapeutics More...

• New US Patent Grant for ValiRx Plc's Cancer Screening Gene Biomarker More...

• How Payers View Pfizer Inc. (PFE)'s Rheumatoid Arthritis Pill More...

• U.S. FDA Approves Bristol-Myers Squibb Company (BMY) Devens Biologics Manufacturing Facility for Production of ORENCIA® (abatacept) More...

• AstraZeneca PLC (AZN) Chops First Round of CNS R&D Scientists More...

• Watson Pharmaceuticals, Inc. (WPI) Shuts Down Groveport Warehouse, Lays Off 55 More...

• Gamida Cell Ltd. Raises $10 Million to Progress Phase III-Stage Hematologic Cancer Cell Therapy More...

• GlaxoSmithKline (GSK) to Fully Buy Cellzome AG for $99 Million More...

• Cornerstone Therapeutics Inc. to Acquire EKR Therapeutics, Inc. for $125 Million Cash, Plus $25 Million in Milestones More...

• Amylin Pharmaceuticals, Inc. (AMLN) Said to Attract Interest From Pfizer Inc. (PFE), AstraZeneca PLC (AZN), Sanofi (France) (SAN.PA) More...

• Thermo Fisher Scientific (TMO) Acquires All Rights for Pre-eclampsia Biomarker From Nephromics More...

• Furiex Pharmaceuticals, Inc. (FURX) Says Johnson & Johnson (JNJ) Returns Sexual Dysfunction Drug Rights More...

• Bristol-Myers Squibb Company (BMY) and Tsinghua University Enter Strategic Partnership More...

• Scil Proteins GmbH, Ono Pharmaceutical Company, Ltd. Establish Affilin Therapeutics Discovery and Development Collaboration More...

• ChinaBio(R) LLC Release: New China-Australia Research Center to Study TCM More...

• Research and License Agreements between National Cheng Kung University Medical College and Novo Nordisk A/S (NVO) More...

• Promedior Moves Fibrosis Pipeline to Boston, Hires Shire plc (SHPGY) Vet as CEO More...

• Aptiv Solutions Announces the Appointment of Luis Gutierrez as Executive Vice President and Chief Commercial Officer More...

• IntegenX Names Biotechnology Veteran David V. SmithChief Operating Officer More...

• Antares Pharma, Inc. (AIS) Appoints LeRoux JoosteSenior Vice President Pharmaceutical Sales and Marketing More...

• Medivir AB (MVIRb.F) Release: New Executive Vice President Commercial Appointed More...

• Aeolus Pharmaceuticals Inc. (AOLS.OB) Announces Second Quarter Fiscal Year 2012 Financial Results More...

• Athersys, Inc. Reports First Quarter 2012 Results More...

• Atrium Innovations Announces 2012 First Quarter Financial Results More...

• AxoGen, Inc. (LECT) Announces Record First Quarter 2012 Revenues More...

• BioLineRx Ltd. Reports First Quarter 2012 Results More...

• Biotechnology Industry Organization (BIO) to Testify at Congressional Hearing on 2012 Farm Bill Energy Programs More...